Newsroom

November 14, 2024

There's a Nearly 100 Percent Accurate Baby Gender Predictor

Read more
October 27, 2024

Do at-home gender test kits work?

Read more
November 12, 2024

Myriad Genetics, Healthcare Marketing Impact Awards 2024

Read more
November 13, 2024

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

Read more
October 17, 2024

Myriad and Flatiron Integrate Genetic Testing with Electronic Medical Record Platform

Read more
November 10, 2024

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

Read more
September 25, 2024

Dr. Thaïs Aliabadi Is Hollywood’s Go-To OB/GYN

Read more
previous slide
    next slide

    Scientific publications

    See all

    High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification

    Read publication
    NPWH 2023

    Menopausal symptom management considerations in patients at high risk for breast cancer

    Read publication
    AUA Western 2023

    Active surveillance selection and durability in men with NCCN intermediate-risk, localized prostate cancer...

    SMFM 2024

    High positive predictive value of 22q11.2 microdeletion screening by prenatal cell-free DNA testing that...

    Read more
    ASCO 2024

    Improving a Polygenic Risk Score (PRS) for breast cancer (BC) risk assessment in diverse ancestries

    Read more
    previous slide
      next slide

      Press releases

      See all

      Jan 23, 2025

      Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

      Read more

      Jan 21, 2025

      Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

      Read more

      Jan 15, 2025

      Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

      Read more

      Jan 09, 2025

      Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

      Read more

      Public relations contacts

      Glenn Farrell, Kate Schraml, Megan Manzari

      pr@myriad.com

      Investor relations contacts

      Matt Scalo

      ir@myriad.com
      X social media icon Linkedin social media icon

      About Myriad Genetics

      Myriad Genetics is a leader in genetic testing and precision medicine, providing insights that help people take control of their health and enable healthcare providers to better detect, treat and prevent disease. 

      • Early insights helped Ashley prepare

        “Carrier screening empowers you to make the right decisions. Not only are you making a decision for yourself right now but you’re making a decision for the next 80, 90, 100 years to create a better life for you and your baby.”
        Watch Ashley's story

      • Prenatal screening gave Hannah time to plan

        “Once we got the noninvasive prenatal screening results back, we were able to meet with a lot more physicians.”

      • How Prolaris provided clarity for his prostate cancer treatment plan

        “Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
        Watch Tim's story
      previous slide
        next slide